Advertisement

Antenatal glucocorticoid treatment in the prevention of neonatal RDS

  • V. Ragosch
  • U. Lorenz
  • B. Arabin
  • S. Jürgens
  • H. Weitzel
Chapter

Abstract

Antenatal glucocorticoid administration in order to prevent neonatal respiratory distress syndrome (RDS) has been an established regimen for over 15 years [1]. Use of such therapy is indicated in all cases in which premature delivery is expected or medical reasons require it [2]. Nevertheless, this treatment is only effective to a limited extent and, as before, a considerable number of premature children die of pulmonary complications. Therefore every obstetric unit has to re-evaluate the data in this particular field from time to time.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Liggins, G. C. and Howie, R. N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515.Google Scholar
  2. [2]
    Lorenz, U. Antepartale Lungenreifebestimmung durch Fruchtwasseranalyse, Berlin-Heidelberg-New York: Springer-Verlag, 1982.CrossRefGoogle Scholar
  3. [3]
    Papageorgiou, A. N., Colle, E., Farri-Kostopoulos, E. and Gelfand, M. M. Incidence of respiratory distress syndrome following antenatal betamethasone: role of sex, type of delivery and prolonged rupture of membranes. Pediatrics 1981; 67: 614–17.Google Scholar

Copyright information

© Macmillan Publishers Limited 1991

Authors and Affiliations

  • V. Ragosch
  • U. Lorenz
  • B. Arabin
  • S. Jürgens
  • H. Weitzel

There are no affiliations available

Personalised recommendations